13F filer · CIK 2100119 ↗
Vanguard Capital Management
You are looking at Q2 2022. See the latest, Q2 2026 →
Reported value
$3.56T
−16% on the quarter before
Positions
4,621
109 new · 114 sold out
Top 10
19.9%
of the value
Est. gain
−$702.50B
on stocks held all quarter
Est. return
−16.7%
on those stocks since Q1 2022
Positions as of Jun 30, 2022, from Vanguard Capital Management's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 30% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2022. Striped tiles are options.
Largest buys
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Warner Bros Discovery Inc~$2.34BNew · 0.0% → 0.1%+174,132,234 shares
- Tesla~$2.07BAdded · 1.7% → 1.3%+3,067,546 shares
- Microsoft~$1.67BAdded · 4.5% → 4.5%+6,510,850 shares
- Vici Pptys Inc~$1.24BAdded · 0.1% → 0.1%+41,782,152 shares
- Amazon~$1.04BAdded · 2.6% → 2.1%+9,783,922 shares
- Apple~$1.00BAdded · 5.2% → 4.9%+7,323,304 shares
- M & T Bk Corp~$976.0MAdded · 0.1% → 0.1%+6,123,292 shares
- Verizon Communications Inc~$787.2MAdded · 0.4% → 0.5%+15,512,036 shares
- Johnson & Johnson~$778.2MAdded · 1.0% → 1.2%+4,384,110 shares
- Unitedhealth Group Inc~$763.7MAdded · 1.0% → 1.2%+1,486,962 shares
Largest sells
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Cerner Corp~$3.01BSold out · 0.1% → 0.0%−32,129,838 shares
- Occidental Pete Corp~$1.26BCut · 0.1% → 0.1%−21,326,962 shares
- Aspen Technology Inc~$1.05BSold out · 0.0% → 0.0%−6,336,062 shares
- Peoples United Financial Inc~$960.6MSold out · 0.0% → 0.0%−48,056,301 shares
- Zynga Inc~$885.7MSold out · 0.0% → 0.0%−95,858,939 shares
- Discovery Inc~$862.1MSold out · 0.0% → 0.0%−34,527,393 shares
- Anaplan Inc~$841.3MSold out · 0.0% → 0.0%−12,932,736 shares
- Marathon Pete Corp~$833.2MCut · 0.1% → 0.1%−10,135,287 shares
- Pioneer Nat Res Co~$711.6MCut · 0.1% → 0.1%−3,189,771 shares
- Valero Energy Corp~$612.6MCut · 0.1% → 0.1%−5,763,995 shares
Holdings
As of Jun 30, 2022. Changes are in shares against Mar 31, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares +0.6% · price −21.7% | 4.9% | $174.64B | −$48.12B | ||||||||
| MicrosoftCOM · shares +1.0% · price −16.7% | 4.5% | $161.32B | −$32.00B | ||||||||
| AmazonCOM · shares +1.4% · price −34.8% | 2.1% | $73.19B | −$38.58B | ||||||||
| AlphabetCAP STK CL A · shares +1.4% · price −21.6% | 1.4% | $51.48B | −$14.03B | ||||||||
| AlphabetCAP STK CL C · shares +0.3% · price −21.7% | 1.3% | $46.51B | −$12.83B | ||||||||
| TeslaCOM · shares +4.7% · price −37.5% | 1.3% | $45.95B | −$26.34B | ||||||||
| Johnson & JohnsonCOM · shares +1.8% · price +0.2% | 1.2% | $43.05B | +$66.7M | ||||||||
| Unitedhealth Group IncCOM · shares +1.8% · price +0.7% | 1.2% | $42.18B | +$295.1M | ||||||||
| Berkshire Hathaway Inc DelCL B NEW · shares +0.3% · price −22.6% | 1.0% | $36.99B | −$10.80B | ||||||||
| Procter And Gamble CoCOM · shares +2.2% · price −5.9% | 0.90% | $31.98B | −$1.96B | ||||||||
| Exxon Mobil CorpCOM · shares +1.1% · price +3.7% | 0.89% | $31.54B | +$1.11B | ||||||||
| NvidiaCOM · shares +1.5% · price −44.4% | 0.86% | $30.53B | −$24.07B | ||||||||
| Jpmorgan Chase & CoCOM · shares +1.0% · price −17.4% | 0.85% | $30.36B | −$6.33B | ||||||||
| MetaCL A · shares −0.03% · price −27.5% | 0.82% | $29.09B | −$11.02B | ||||||||
| Visa Inc.COM CL A · shares +0.6% · price −11.2% | 0.80% | $28.42B | −$3.57B | ||||||||
| Home Depot IncCOM · shares +0.1% · price −8.4% | 0.72% | $25.62B | −$2.34B | ||||||||
| Pfizer IncCOM · shares +2.0% · price +1.3% | 0.72% | $25.61B | +$316.2M | ||||||||
| MastercardCL A · shares +0.9% · price −11.7% | 0.68% | $24.19B | −$3.19B | ||||||||
| Chevron Corp NewCOM · shares −2.3% · price −11.1% | 0.67% | $23.73B | −$2.96B | ||||||||
| Abbvie IncCOM · shares +2.0% · price −5.5% | 0.66% | $23.52B | −$1.35B | ||||||||
| Eli LillyCOM · shares +1.6% · price +13.2% | 0.65% | $23.21B | +$2.67B | ||||||||
| Coca Cola CoCOM · shares +2.3% · price +1.5% | 0.64% | $22.61B | +$319.6M | ||||||||
| Pepsico IncCOM · shares +2.1% · price −0.4% | 0.60% | $21.20B | −$89.7M | ||||||||
| Merck & Co IncCOM · shares +2.3% · price +11.1% | 0.57% | $20.15B | +$1.97B | ||||||||
| Bk Of America CorpCOM · shares +1.3% · price −24.5% | 0.52% | $18.65B | −$5.97B | ||||||||
| Total · 4,621 positions | 100% | $3.56T | −$702.50B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2022 to Q2 2022: 4,510 stocks held throughout, down $702.50B (−16.7%).
- Eli Lilly+$2.67B+13%
- Merck & Co Inc+$1.97B+11%
- Exxon Mobil Corp+$1.11B+4%
- IBM+$860.1M+9%
- Bristol-Myers Squibb Co+$781.4M+5%
- Nvidia−$24.07B−44%
- Tesla−$26.34B−38%
- Microsoft−$32.00B−17%
- Amazon20:1 split−$38.58B−35%
- Apple−$48.12B−22%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 25 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $4.68T+17% | SEC ↗ |
| Q1 2026 | May 15, 2026 (amended) | $4.00T−42% | SEC ↗ |
| Q4 2025 | Jan 29, 2026 | $6.90T+3% | SEC ↗ |
| Q3 2025 | Nov 7, 2025 | $6.68T+8% | SEC ↗ |
| Q2 2025 | Aug 11, 2025 | $6.18T+12% | SEC ↗ |
| Q1 2025 | May 9, 2025 | $5.53T−4% | SEC ↗ |
| Q4 2024 | Feb 11, 2025 | $5.74T+3% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $5.58T+7% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $5.21T+3% | SEC ↗ |
| Q1 2024 | May 10, 2024 | $5.05T+10% | SEC ↗ |
| Q4 2023 | Mar 11, 2024 (amended) | $4.58T+12% | SEC ↗ |
| Q3 2023 | Dec 18, 2023 (amended) | $4.07T−3% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $4.22T+7% | SEC ↗ |
| Q1 2023 | Jul 14, 2023 (amended) | $3.93T+7% | SEC ↗ |
| Q4 2022 | Feb 10, 2023 | $3.67T+8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $3.40T−4% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $3.56T−16% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $4.23T−4% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $4.40T+9% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $4.03T+0% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $4.02T+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $3.70T+7% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $3.45T+14% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $3.02T+7% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $2.82T+20% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $2.35T−20% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $2.93T+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $2.70T+1% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $2.66T+4% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $2.55T+15% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $2.23T−13% | SEC ↗ |
| Q3 2018 | Dec 13, 2018 (amended) | $2.56T+7% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $2.39T+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $2.29T−0% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $2.29T+7% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $2.14T+5% | SEC ↗ |
| Q2 2017 | Aug 24, 2017 (amended) | $2.03T+4% | SEC ↗ |
| Q1 2017 | May 12, 2017 | $1.95T+9% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $1.79T+5% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $1.70T+6% | SEC ↗ |
| Q2 2016 | Aug 10, 2016 | $1.61T+4% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $1.54T | SEC ↗ |